Conference program

March 26

8.30-9.00 – Gathering

Session 1. 9.00-10.30. Greetings by public figures and policy makers.

Enhancing research, development and education for healthy longevity and prevention of aging-related diseases – an essential part of the preparedness for population aging.

Israel can and should become an important contributor to healthy longevity research, development and education.

In Memory of Rafi Eitan, the founder of the Senior Citizens Movement and Vetek (Seniority) Association – the Movement for Longevity and Quality of Life.

  • Moshe Bar Siman Tov. Director General. Ministry of Health.
  • Michael Kleiner.
  • Yuval Eitan.
  • Prof. Noah Efron. Graduate Program in Science, Technology and Soceity, Bar Ilan University
  • Dr. Ilia Stambler. Vetek Association and Bar Ilan University.

Building the longevity ecosystem for Israel and international collaboration.

MOH Programs in addressing the population aging in Israel, the importance of medical research.

10.30-11.00. Break

Session 2. Between fundamental aging research and commercialization of longevity therapies. A road ahead or a death valley?

Longevity Industry Framework and the Financial Commoditization of Longevity Industrialization.

Following the data. Key trends in the longevity science and market

Technologies for aging well.

Redefining the measurement and delivery of healthcare for older persons.

Translation of biogerontological research to therapy: scientific, regulatory and policy bottlenecks and potential solutions

12.15-13.30 LUNCH

Session 3. Healthy longevity extension. The goals and the means.

LEV Foundation’s activities in research, development and education.

The nascent Longevity movement in Latin America.

Advances toward longevity therapies.

How to make longevity a mainstream topic.

The cure for ageing will happen – but it will not be something physical.

Citizens sharing health data for clinical trials for healthy longevity.

March 27

Session 1. Pathways and crossroads to healthy longevity. The main promises and challenges of geroscience.

Scientific advances toward healthy life extension.

Deep bio solutions for longevity.

Undoing loss of microvascular homeostasis promotes healthy aging.

Senescent cells in aging: the good, the bad and the ugly.

Revitalizing the immune system with young mitochondria.

Genome Stability in Healthy Aging and Disease

  • 10.30-10.40. Dr. David Izhaky. EMIT. Targeting Radiation-Induced Aging for Longevity Therapeutics

10.40-11.00. Break

Session 2. Clinical evaluation criteria for aging – aging clocks, biomarkers, metrics of intrinsic functional capacity. Recognizing degenerative aging as a medical condition.

DNA Analysis for Longevity: Becoming masters of our DNA and making health benefits available to all.

What role does the environment play in longevity? Epigenetic approach.

Combinatorial approach to aging.

Making extension of healthy longevity a norm through digital aging clocks

  • 12.00-12.15. Anton Kulaga. Systems Biology of Aging Group, Institute of Biochemistry of the Romanian Academy of Sciences, and International Longevity Alliance (ILA).

Longevity genetics for everyone – test case: Just-DNA-Seq opensource personal genomics platform.

12.15-13.30 LUNCH

Session 3. Between geriatric medicine and longevity medicine. What can be offered now and in the near future?

Healthy Longevity Medicine – optimizing the biological age of the individual performance, clinical experience.

The application of stem cell therapeutic approaches for human aging and related national policies.

  • 14.00-14.15. Prof. Kunlin Jin. International Society on Aging and Disease (ISOAD).

Microcirculatory Dysfunction and Aging.

Novel placental cell regenerative treatment for healthy longevity.

  • 14.30-14.45. Dr. Mario Krause. European Society of Preventive, Regenerative and Anti-Aging Medicine (ESAAM).

If you are looking for longevity – don’t die from cancer.

  • 14.45-15.00. Dr. Arseniy Trukhanov. European Society of Preventive, Regenerative and Anti-Aging Medicine (ESAAM).

The Road map of Anti-Aging medicine in Europe: 2030.

15.00-15.30. Discussion. Conference resolution adoption. Closing remarks.